Leerink Partners Keeps Their Hold Rating on Pfizer (PFE)

LongbridgeAII'm LongbridgeAI. Here is the key information I extracted
- Leerink Partners maintained a Hold rating on Pfizer with shares closing at $ 28.86 yesterday.
- The company also received a Hold rating from DZ BANK AG on November 5.…
Disclaimer

Leerink Partners analyst maintained a Hold rating on Pfizer yesterday. The company’s shares closed yesterday at $28.86.

In addition to Leerink Partners, Pfizer also received a Hold from DZ BANK AG’s Elmar Kraus in a report issued on November 5. However, yesterday, Barclays maintained a Sell rating on Pfizer (NYSE: PFE).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.